Needham & Company Reiterate Buy Following Infoblox (BLOX) Analyst Day

Go back to Needham & Company Reiterate Buy Following Infoblox (BLOX) Analyst Day

Pre-Open Stock Movers 05/29: (TBIO) (HRTX) (NQ) Higher; (FRO) (SPLK) (CYBR) Lower (more...)

May 29, 2015 9:27 AM EDT

Transgenomic, Inc. (NASDAQ: TBIO) 45% HIGHER; announced the launch of its new Multiplexed ICE COLD-PCR (MX-ICP) CLIA service for mutation detection in cancer patients to enable more informed diagnoses, better treatment decisions and ongoing... More

Needham & Company Raises Price Target on Infoblox (BLOX) Following 3Q Results

May 29, 2015 7:38 AM EDT

Needham & Company maintains a Buy rating on Infoblox (NYSE: BLOX), and raised the price target to $33.00 (from $27.00), following 3Q results. BLOX reported revenues of $78.1M. EPS was reported at $0.12, compared to $0.07 estimates.

Analyst Alex Henderson commented, "Infoblox delivered a strong quarter with Revenues of... More

Infoblox (BLOX) PT Bumped to $30 at Piper Jaffray on 'Very Impressive' Q3

May 29, 2015 6:51 AM EDT

Piper Jaffray analyst Troy Jensen reiterated an Overweight rating and boosted his price target on Infoblox (NYSE: BLOX) to $30.00 (from $28.00) following 'very impressive' Q3 results.

Jensen commented, "We were once again very impressed with BLOXs earnings results, and convinced the companys new... More